The adenosine deaminase inhibitor erythro-9-[2-hydroxyl-3-nonyl]-adenine decreases intestinal permeability and protects against experimental sepsis: a prospective, randomised laboratory investigation
-
* Corresponding author: Markus A Weigand markus.weigand@med.uni-heidelberg.de
- Equal contributors
Critical Care 2008, 12:R125 doi:10.1186/cc7033
Accesses
- Last 30 days: 75 accesses
- Last 365 days: 700 accesses
- All time: 3321 accesses